EQT Fund Management S.a r.l. — 13F Holdings & Portfolio
CIK 1834239 · latest 13F-HR filed 2026-11-12
EQT Fund Management S.a r.l. manages $947.4M in 13F-reported U.S. long-equity assets across 6 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are WAY (66.54%), PHVS (11.47%), OCS (6.85%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 1 new position and exited 0; 1 existing position rose in reported value and 4 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-11-12
vs 2026-06-30
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q3 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q2 26 → Q3 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
5 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 100%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 30, 2026.
LUXEMBOURG L-2449
Luxembourg
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| EQT AB Control | SHAREHOLDER since Aug 2017 | 75% or more | Foreign Entity |
| VELDMAN, PETER Control | DIRECTOR since Jan 2017 | Less than 5% | Individual |
| Burnas, Patrik | BOARD MEMBER since Mar 2023 | Less than 5% | Individual |
| DE WET SNYDERS, CHRISTIAAN | BOARD MEMBER since Jan 2025 | Less than 5% | Individual |
| HUDA, SARA | BOARD MEMBER since Dec 2022 | Less than 5% | Individual |
| Sjocrona, Magnus | BOARD MEMBER since Mar 2023 | Less than 5% | Individual |
Ownership & leadership changes · 4 filings with changes since Jun 19, 2017
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedSTONE, JOSHUA · BOARD MEMBER · Less than 5% · listed since Dec 2015
- AddedDE WET SNYDERS, CHRISTIAAN · BOARD MEMBER · Less than 5%
- AddedBurnas, Patrik · BOARD MEMBER · Less than 5%
- AddedHUDA, SARA · BOARD MEMBER · Less than 5%
- AddedSTONE, JOSHUA · BOARD MEMBER · Less than 5%
- AddedSjocrona, Magnus · BOARD MEMBER · Less than 5%
- No longer listedEQT HOLDINGS COOPERATIEF W.A. · SHAREHOLDER · 75% or more · indirect via EQT HOLDINGS INTERNATIONAL BV · control person · listed since Jun 2013
- No longer listedEQT INTERNATIONAL HOLDINGS BV · SHAREHOLDER · 75% or more · indirect via EQT AB · control person · listed since Jan 2012
- No longer listedEQT AB · SHAREHOLDER · 75% or more · indirect via EQT SD (UK) LTD · control person · listed since Feb 2012
- No longer listedEQT SD (UK) LTD · SHAREHOLDER · 75% or more · control person · listed since May 2017
- AddedEQT AB · SHAREHOLDER · 75% or more · control person
- ListedEQT AB · SHAREHOLDER · 75% or more · indirect via EQT SD (UK) LTD · control person
- ListedEQT HOLDINGS COOPERATIEF W.A. · SHAREHOLDER · 75% or more · indirect via EQT HOLDINGS INTERNATIONAL BV · control person
- ListedEQT INTERNATIONAL HOLDINGS BV · SHAREHOLDER · 75% or more · indirect via EQT AB · control person
- ListedEQT SD (UK) LTD · SHAREHOLDER · 75% or more · control person
- ListedVELDMAN, PETER · DIRECTOR · Less than 5% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Trims
- OCULIS HOLDING AG-$31.5M -32.7%
- EVOMMUNE INC-$26.6M -37.8%
- PHARVARIS N V-$9.8M -8.3%
- AGOMAB THERAPEUTICS NV-$9.7M -14.5%
EQT Fund Management S.a r.l. Holdings (2026-09-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | WAYSTAR HLDG CORP | WAY | 946784105 | $630.4M | 66.54% | 24,879,437 | SH |
| 2 | PHARVARIS N V | PHVS | N69605108 | $108.6M | 11.47% | 3,424,609 | SH |
| 3 | OCULIS HOLDING AG | OCS | H5870P102 | $64.9M | 6.85% | 6,950,294 | SH |
| 4 | AGOMAB THERAPEUTICS NV | AGMB | 00860C102 | $57.1M | 6.02% | 5,141,992 | SH |
| 5 | EVOMMUNE INC | EVMN | 30054Y107 | $43.7M | 4.61% | 5,288,313 | SH |
| 6 | ELECTRA THERAPEUTICS INC | ETRA | 284825106 | $42.7M | 4.51% | 3,795,281 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-12 | $947.4M | 6 | 0001193125-26-457159 |
| 2026-06-30 | 2026-08-13 | $862.6M | 5 | 0001193125-26-349398 |
| 2026-03-31 | 2026-05-14 | $1.02B | 5 | 0001193125-26-224227 |
| 2025-12-31 | 2026-02-11 | $1.11B | 4 | 0001193125-26-046725 |
| 2025-09-30 | 2025-11-14 | $1.86B | 4 | 0001193125-25-281778 |
LUXEMBOURG, N4 L-2449